SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (14471)2/9/1998 8:39:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
Actually, it was posted:
Message 3367676
and has been linked to the Lehman Brothers table at home.att.net
but I expect more analysts' reports soon, so keep us updated. The current Lehman report still uses old earnings estimates, but Thursday's report should generate some re-evaluations (Lehman had a $0.32 loss for 4Q, which came in at a $0.09 loss).

I noticed the Free Edgar was having some technical problems. Hope they can get new Farallon filings up on time.



To: celeryroot.com who wrote (14471)2/9/1998 8:45:00 AM
From: Abuckatatime  Respond to of 32384
 
"New Diabetes Treatment?" (please excuse if posted previously) Brief blurb in Chicago Tribune based on article in biotech journal.

chicago.tribune.com

ncbi.nlm.nih.gov